Alpine Peaks Capital’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-242,000
| Closed | -$535K | – | 25 |
|
|
2025
Q1 | $535K | Buy |
242,000
+38,000
| +19% | +$84K | 0.48% | 25 |
|
|
2024
Q4 | $1.11M | Sell |
204,000
-75,024
| -27% | -$409K | 0.91% | 23 |
|
|
2024
Q3 | $2.32M | Sell |
279,024
-17,876
| -6% | -$149K | 1.38% | 21 |
|
|
2024
Q2 | $2.13M | Sell |
296,900
-76,000
| -20% | -$544K | 1.31% | 24 |
|
|
2024
Q1 | $3.23M | Sell |
372,900
-32,000
| -8% | -$277K | 1.86% | 22 |
|
|
2023
Q4 | $2.65M | Buy |
404,900
+45,600
| +13% | +$299K | 1.61% | 22 |
|
|
2023
Q3 | $3.59M | Buy |
359,300
+29,876
| +9% | +$299K | 2.51% | 21 |
|
|
2023
Q2 | $4.09M | Buy |
329,424
+88,924
| +37% | +$1.11M | 2.87% | 19 |
|
|
2023
Q1 | $3.37M | Buy |
240,500
+59,000
| +33% | +$827K | 2.54% | 20 |
|
|
2022
Q4 | $2.6M | Buy |
+181,500
| New | +$2.6M | 2.1% | 22 |
|